Not provided
Not provided
Not provided
Not provided
Practical difficulties in starting active recruitment.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study tests a structured referral process for opioid overdose survivors, from pre-hospital emergency care to long-term treatment of the individual's substance use-related disorder.
Randomized controlled trial. Subjects are included if they are being treated by an ambulance in the Malmö uptake are for an opioid overdose requiring naloxone antidote administration, and if they sign informed written consent to the study. Subjects are randomized by ambulance staff to either an active intervention, or a control condition:
Intervention: A telephone alert signal is sent from ambulance staff after successful naloxone reversal of an opioid overdose, leading to an active outreach effort from the staff of the addiction research facility, where staff locate the individual and offer her/him formal inclusion in the study.
Control: No telephone alert signal is sent, and the active outreach procedure is not carried out. Ambulance staff hand over written information to the individual about how she/he can apply actively for treatment.
Primary outcome is entry into formal assessment and treatment of the substance use disorder.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | Telephone alert signal from ambulance staff to out-patient substance use disorder treatment facility, for active outreach aiming to locate and include the patient in long-term evidence-based treatment for the substance use disorder. |
|
| Control | Active Comparator | Information-only. Ambulance staff hand over written information to the individual about how to seek treatment for the substance use disorder. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Active treatment referral of opioid overdose survivors to long-term treatment | Behavioral | Telephone alert and outreach for inclusion, assessment and intake into long-term evidence-based treatment of the substance use disorder. |
| Measure | Description | Time Frame |
|---|---|---|
| Treatment entry | Entry into formal assessment for evidence-based treatment of opioid use disorder | Two weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Treatment retention | Retention in opioid maintenance treatment or other relevant evidence-based treatment for the substance-related condition, as measured in treatment records, and including the analysis of predictors of retention | 3, 6, 12, 24 and 36 months |
| Treatment outcome (urinalysis) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Anders Håkansson, MD, PhD | Lund University. Region Skåne. | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Malmö Addiction Center | Malmö | Sweden |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009293 | Opioid-Related Disorders |
| D019966 | Substance-Related Disorders |
| ID | Term |
|---|---|
| D000079524 | Narcotic-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Control | Behavioral | Written information from ambulance staff to the patient about how to seek treatment. Patient is able to contact the research treatment facility through a specific phone number, making it possible to study treatment entry in the information-only control condition. |
|
|
Drug-free status in treatment, as documented from hospital records of drug-free urines |
| 3, 6, 12, 24 and 36 months |
| Treatment outcome (hair analysis) | Drug-free status in treatment, as documented by hair analysis | 3 months |
| Treatment outcome (self-report) | Drug-free status in treatment, described through self-report (AUDIT, DUDIT) | 3, 6, 12, 24 and 36 months |
| Treatment outcome (quality of life) | Self-report, EQ-5D (European Quality of life - 5 Dimensions) and visual analogue scale | 3, 6, 12, 24 and 36 months |